Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals: An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI)

PUBLISHED: 2020 CATEGORY: Health care providers TYPE: External Link Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals: An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI)

Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals: An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI) Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals: An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI)

Corporate Authors: National Advisory Committee on Immunization

Publisher: Publisher Public Health Agency of Canada